Skip to main content

Table 1 Patient demographic and clinical characteristics (n = 17)

From: Pain in castration-resistant prostate cancer with bone metastases: a qualitative study

Characteristic

 

Age in years, mean [range]

71.1 [53 - 86]

Mean years since prostate cancer diagnosis

7.0

Mean years since onset of bone metastases

1.7

Cancer stage*

 

   Well differentiated (Gleason score 2-4)

2 (12%)

   Moderately differentiated (Gleason score 5-7)

5 (29%)

   Poorly differentiated or undifferentiated (Gleason score 8-10)

5 (29%)

Patient-rated overall bone pain**

 

   Very mild

3 (18%)

   Mild

3 (18%)

   Moderate

8 (47%)

   Severe

2 (12%)

   Very severe

0

Pain relief medication ***

 

   Ibuprofen

3 (18%)

   Percocet® (acetaminophen; oxycodone hydrochloride)

8 (47%)

   Lortab® (acetaminophen, hydrocodone bitartrate)

1 (6%)

   Oxycontin® (oxycodone hydrochloride)

5 (29%)

   Tylenol® (acetaminophen)

4 (24%)

   Zometa® (Zoledronic acid)

2 (12%)

   Vicodin® (acetominophen, hydrocodone bitartrate)

1 (6%)

   Darvocet® (acetominiphen; propoxyphen hydrocholoride)

1 (6%)

  1. *Missing data (n = 4) ** Missing data (n = 1) *** Patient could be receiving multiple pain relief medications